This trial is for people who have already been taking parsaclisib in other studies, and will continue to take it either alone or with other drugs.
- B Cell Cancers
1 Primary · 0 Secondary · Reporting Duration: Through study completion, an average of 5 years
Side Effects for
4 Treatment Groups
parsaclisib + ruxolitinib
1 of 4
parsaclicib + itacitinib
1 of 4
parsaclisib + ibrutinib
1 of 4
1 of 4
200 Total Participants · 4 Treatment Groups
Primary Treatment: Parsaclisib · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has the FDA given Parsaclisib its stamp of approval?
"Given the Phase 2 status, our team at Power has evaluated Parsaclisib's safety as a score of 2. Currently, there is some data affirming its security but no studies yet that have proven efficacy." - Anonymous Online Contributor
How much healthcare infrastructure is being utilized for this research endeavor?
"At the moment, 26 medical facilities are running this clinical trial. Aside from Long Beach, Kansas City and Seattle, there are 23 other sites in various cities across the nation. For ease of access for participants it is encouraged to select a location closest to you." - Anonymous Online Contributor
Is enrollment for the trial still available to interested participants?
"Affirmative. The clinical trial directory hosted on the governmental website highlights that this research has been open for applications since August 3rd 2020 and is currently in search of 200 participants across 26 facilities." - Anonymous Online Contributor
What is the current capacity for participants in this medical study?
"To meet the demands of this trial, 200 qualifying patients must be recruited. Incyte Corporation will be handling operations from two locations: Innovative Clinical Research Institute in Long Beach, California and Saint Luke'S Hospital of Kansas City in Missouri." - Anonymous Online Contributor
What evidence exists of Parsaclisib being examined in other scientific experiments?
"Currently, there are 39 ongoing clinical trials focused on Parsaclisib; four of them in their final stage. These studies have been established mainly in Rozzano but also span 1280 other locations worldwide." - Anonymous Online Contributor
Has this type of experiment been conducted previously or is it a pioneering endeavor?
"Presently, 39 research trials involving Parsaclisib are underway across 137 cities and 28 states. This drug was initially tested in 2013, when Incyte Corporation sponsored a trial with 121 participants that completed Phase 1 of the approval process. Since then, 20 separate studies have been carried out." - Anonymous Online Contributor